Could gamma scintigraphy strengthen your next regulatory submission?
Our gamma scintigraphy studies help pharma companies understand lung deposition, inhaler performance, and drug delivery in respiratory products. We provide clinical imaging support for inhaled and nasal drug development within an MHRA-approved clinical research environment.
If your inhaled programme is approaching clinical or regulatory review, scintigraphy data strengthens your submission.
Book a Consultation Call
We will contact you within 24 hours.